Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
фото показано с : btcmanager.com

2021-8-18 16:00

18th August 2021, Basel, Switzerland — For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace Molecule, and VitaDAO, a decentralized collective (DAO) funding longevity research, and the University of Copenhagen. This innovationRead More

Similar to Notcoin - TapSwap on Solana Airdrops In 2024

origin »

Molecule (MOL) на Currencies.ru

$ 0.0001007 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 0.00 %
Cегодня L: $0.0001007 - H: $0.0001007
Капитализация $1.287m Rank 99999
Доступно / Всего 12.782b MOL

research longevity molecule vitadao transfer biopharma result

research longevity → Результатов: 2


ChainXchange Day 2: Thomas Lee, Paul Krugman Discuss Bitcoin Longevity

The second day of Las Vegas Blockchain Week and the ChainXchange blockchain convention has concluded. Today’s activities included discussions and lectures carried out by prominent cryptocurrency supporters and skeptics, including representatives from Ripple and NEM, as  well as Nobel Prize winning economist and perpetual crypto bear Paul Krugman.

2018-8-15 09:10